COMPOSITION: Sitagliptin 100 mg with metformin 500 mg Prolonged Release tablets
Pack – 10 Tablets/strip
Mode of Action

• A novel DPP4 inhibitor
• Elevates GLP 1 and GIP Effectively
• Ensure 2 fold increase in post prandial GLP 1 level
• Improves incretin and insulin secretion
• Removes insulin resistance
• Reduces HbA1c, PPG levels

Indication – Diabetic patients with cardio vascular disease,Elderly diabetic patients
Type 2 Diabetes
Dosage – Once daily
Contraindication – severe ketosis, diabeticcoma, hypersensitivity
Drug interaction – Aspirin, Atorvastatin, Pregabalin